Arena Pharmaceuticals Inc (ARNA.A)

ARNA.A on American Stock Exchange

4.33USD
27 Mar 2015
Change (% chg)

$0.00 (+0.02%)
Prev Close
$4.33
Open
$4.44
Day's High
$4.44
Day's Low
$4.29
Volume
15,154
Avg. Vol
29,810
52-wk High
$7.21
52-wk Low
$3.26

ARNA.A

Chart for ARNA.A

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. The Company’s drug, BELVIQ (lorcaserin HCl), was approved by the United States Food and Drug Administration for chronic weight management in adults. The Company also has... (more)

Overall

Beta: -0.52
Market Cap(Mil.): $1,045.54
Shares Outstanding(Mil.): 241.46
Dividend: --
Yield (%): --

Financials

  ARNA.A Industry Sector
P/E (TTM): -- 132.14 40.89
EPS (TTM): -0.28 -- --
ROI: -25.31 -0.52 16.10
ROE: -86.94 -2.20 16.95
Search Stocks

After slam dunk, NBA eyes growth in Mexico but no franchise yet

MEXICO CITY - Delighted following a packed house at Wednesday's regular clash between the Houston Rockets and Minnesota Timberwolves, the NBA is eyeing further growth in Mexico next year but any eventual franchise south of the border is still some ways off.

14 Nov 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks